The concentration of IL‐18 in the serum of fatty liver patients (911.97; 775.55–1130.03 pg/mL) is higher than that of healthy controls (483.09; 402.52–599.70 pg/mL), and its pathogenesis is more complicated. This evidence concerns the gene IL18 and Hepatic steatosis.